A
Andrey V. Susekov
Researcher at Academy of Medical Sciences, United Kingdom
Publications - 22
Citations - 1853
Andrey V. Susekov is an academic researcher from Academy of Medical Sciences, United Kingdom. The author has contributed to research in topics: Statin & Hypertriglyceridemia. The author has an hindex of 9, co-authored 18 publications receiving 1394 citations.
Papers
More filters
Journal ArticleDOI
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Gerald F. Watts,Samuel S. Gidding,Anthony S. Wierzbicki,Peter P. Toth,Peter P. Toth,Rodrigo Alonso,W. Virgil Brown,Eric Bruckert,Joep C. Defesche,Khoo Kah Lin,Michael Livingston,Pedro Mata,Klaus G. Parhofer,Frederick J. Raal,Raul D. Santos,Eric J.G. Sijbrands,William G. Simpson,David R. Sullivan,Andrey V. Susekov,Brian Tomlinson,Albert Wiegman,Shizuya Yamashita,John J.P. Kastelein +22 more
TL;DR: Recommendations on treatment are based on risk stratification, management of non-cholesterol risk factors, and safe and effective use of LDL lowering therapies, and the use of emerging therapies for FH is foreshadowed.
Journal ArticleDOI
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
Scott M. Grundy,Hidenori Arai,Philip J. Barter,Thomas P. Bersot,D. John Betteridge,Rafael Carmena,Ada Cuevas,Michael H. Davidson,Jacques Genest,Y. Antero Kesäniemi,Shaukat Sadikot,Raul D. Santos,Andrey V. Susekov,Rody G. Sy,S. LaleTokgözoglu,Gerald F. Watts,Dong Zhao +16 more
TL;DR: An international panel of the International Atherosclerosis Society has developed a new set of recommendations for management of dyslipidemia, identifying non-high density lipoprotein cholesterol (non-HDL-C) as the major atherogenic lipoproteins.
Journal ArticleDOI
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
John J.P. Kastelein,Kevin C. Maki,Andrey V. Susekov,Marat V. Ezhov,Børge G. Nordestgaard,Ben N. Machielse,Douglas Kling,Michael H. Davidson +7 more
TL;DR: OM3-FFA achieved the primary end point for TG lowering and secondary end point of non-HDL-C lowering at 2, 3, and 4 g/d in persons with severe hypertriglyceridemia in a multinational, double-blind, randomized, out-patient study.
Journal ArticleDOI
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
Antonio J. Vallejo-Vaz,Martina De Marco,C. Stevens,Asif Akram,Tomáš Freiberger,G. Kees Hovingh,John J.P. Kastelein,Pedro Mata,Frederick J. Raal,Raul D. Santos,Handrean Soran,Gerald F. Watts,Marianne Abifadel,Carlos A. Aguilar-Salinas,Mutaz Alkhnifsawi,Fahad Alkindi,Fahad Alnouri,Rodrigo Alonso,Khalid Al-Rasadi,Ahmad Al-Sarraf,T.F. Ashavaid,Christoph J. Binder,Martin Prøven Bogsrud,Mafalda Bourbon,Eric Bruckert,Krzysztof Chlebus,Pablo Corral,Olivier S. Descamps,Ronen Durst,Marat V. Ezhov,Zlatko Fras,Jacques Genest,Urh Groselj,Mariko Harada-Shiba,Meral Kayıkçıoğlu,Katarina Lalic,Carolyn S.P. Lam,Gustavs Latkovskis,Ulrich Laufs,Evangelos Liberopoulos,Jie Lin,Vincent Maher,Nelson Majano,A. David Marais,Winfried März,Erkin M. Mirrakhimov,André R. Miserez,Olena Mitchenko,Hapizah Nawawi,Børge G. Nordestgaard,György Paragh,Zaneta Petrulioniene,Belma Pojskic,Arman Postadzhiyan,Ashraf Reda,Željko Reiner,Wilson E Sadoh,Amirhossein Sahebkar,Abdullah Shehab,Aleksander B Shek,Mario Stoll,Ta-Chen Su,Tavintharan Subramaniam,Andrey V. Susekov,Phivos Symeonides,Myra Tilney,Brian Tomlinson,Thanh-Huong Truong,Alexandros D. Tselepis,Anne Tybjærg-Hansen,Alejandra Vázquez-Cárdenas,Margus Viigimaa,Branislav Vohnout,Elisabeth Widen,Shizuya Yamashita,Maciej Banach,Dan Gaita,Lixin Jiang,Lennart Nilsson,Lourdes Ella G. Santos,Heribert Schunkert,Lale Tokgozoglu,Josip Car,Alberico L. Catapano,Kausik K. Ray +84 more
TL;DR: FH is a recognised public health concern, with overall suboptimal identification and under-treatment, and efforts and initiatives to improve FH knowledge and management are underway, but support from health authorities and better funding are greatly needed.
Journal ArticleDOI
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
Gerald F. Watts,Samuel S. Gidding,Anthony S. Wierzbicki,Peter P. Toth,Peter P. Toth,Rodrigo Alonso,W. Virgil Brown,Eric Bruckert,Joep C. Defesche,Khoo Kah Lin,Michael Livingston,Pedro Mata,Klaus G. Parhofer,Frederick J. Raal,Raul D. Santos,Eric J.G. Sijbrands,William G. Simpson,David R. Sullivan,Andrey V. Susekov,Brian Tomlinson,Albert Wiegman,Shizuya Yamashita,John J.P. Kastelein +22 more
TL;DR: Recommendations focus on the detection, diagnosis, assessment, and management of FH in adults and children and set guidelines for clinical purposes, based on risk stratification, management of noncholesterol risk factors, and the safe and effective use of low-density lipoprotein-lowering therapies.